The aim of the study was to study the immunohistochemical expression of B-cell lymphoma 2 (BCL-2) in endometrial carcinoma and to study the correlation of BCL-2 expression with hormone receptor status and transforming growth factor receptors in endometrial carcinoma. This evidence concerns the gene NR4A1 and endometrial carcinoma.